The purpose of this research program is to investigate the mechanisms of hereditary neurological diseases, with the ultimate intent of developing effective treatments for these disorders. Recently, the research has focused on three specific neuromuscular diseases: autosomal recessive spinal muscular atrophy (SMA) due to deficiency of the protein SMN, X-linked spinal and bulbar muscular atrophy (SBMA) due to polyglutamine expansion in the androgen receptor, and myofibrillar myopathy caused by mutations in ZASP. Specific research accomplishments in the past year include the following: (1) evaluation of the effects of proteasome inhibitor treatment in a mouse model of SMA, (2) characterization of the effects of IGF-1 in an animal model of SBMA,(3) identification of interacting proteins for wild type and mutant ZASP and developing animal models with ZASP mutation.

Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
2011
Total Cost
$1,689,752
Indirect Cost
City
State
Country
Zip Code
Cristofani, Riccardo; Crippa, Valeria; Rusmini, Paola et al. (2017) Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases. Autophagy 13:1280-1303
Martin, Jasmin E; Nguyen, TrangKimberly T; Grunseich, Christopher et al. (2017) Decreased Motor Neuron Support by SMA Astrocytes due to Diminished MCP1 Secretion. J Neurosci 37:5309-5318
Abera, Mahlet B; Xiao, Jingbo; Nofziger, Jonathan et al. (2016) ML372 blocks SMN ubiquitination and improves spinal muscular atrophy pathology in mice. JCI Insight 1:e88427
Pourshafie, Naemeh; Lee, Philip R; Chen, Ke-Lian et al. (2016) MiR-298 Counteracts Mutant Androgen Receptor Toxicity in Spinal and Bulbar Muscular Atrophy. Mol Ther 24:937-45
Fischbeck, Kenneth H (2016) Spinal and Bulbar Muscular Atrophy Overview. J Mol Neurosci 58:317-20
Polanco, Maria Josè; Parodi, Sara; Piol, Diana et al. (2016) Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy. Sci Transl Med 8:370ra181
Bott, Laura C; Badders, Nisha M; Chen, Ke-Lian et al. (2016) A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy. Hum Mol Genet 25:1979-1989
Bott, Laura C; Salomons, Florian A; Maric, Dragan et al. (2016) The polyglutamine-expanded androgen receptor responsible for spinal and bulbar muscular atrophy inhibits the APC/C(Cdh1) ubiquitin ligase complex. Sci Rep 6:27703
Foran, Emily; Kwon, Deborah Y; Nofziger, Jonathan H et al. (2016) CNS uptake of bortezomib is enhanced by P-glycoprotein inhibition: implications for spinal muscular atrophy. Neurobiol Dis 88:118-24
Hjelm, B E; Grunseich, C; Gowing, G et al. (2016) Mifepristone-inducible transgene expression in neural progenitor cells in vitro and in vivo. Gene Ther 23:424-37

Showing the most recent 10 out of 41 publications